An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations—fluorescent mutation detection (F‐MD)

We describe an improved, fast, automated method for screening large genes such as BRCA2 for germline genomic mutations. The method is based on heteroduplex analysis, and has been adapted for a high throughput application by combining the fluorescent technology of automated sequencers and robotic sample handling. This novel approach allows the entire BRCA2 gene to be screened with appropriate overlaps in four lanes of an ABI 377 gel. The method will detect all types of mutations, especially point mutations, more reliably and robustly than other commonly used conformational sensitive methods (e.g. CSGE). In addition we show that this approach, which relies on band shift detection, is able to detect single base substitutions that have hitherto only been detectable by direct sequencing methods. Hum Mutat 17:220–232, 2001. © 2001 Wiley‐Liss, Inc.

[1]  M. Stratton,et al.  The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. , 2000, Cancer research.

[2]  J. Mendell,et al.  A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient , 1993, Nature Genetics.

[3]  E. Gross,et al.  A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers , 1999, Human mutation.

[4]  B. Ponder,et al.  Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group. , 1996, American journal of human genetics.

[5]  H. Olsson.  Cancer risks in BRCA2 mutation carriers. , 1999, Journal of the National Cancer Institute.

[6]  Sheila Seal,et al.  BRCA2 mutations in primary breast and ovarian cancers , 1996, Nature Genetics.

[7]  I. Verma,et al.  Transcriptional activation by BRCA1 , 1996, Nature.

[8]  D. Bentley,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.

[9]  D. Schaid,et al.  Genetic heterogeneity in Peutz‐Jeghers syndrome , 2000, Human mutation.

[10]  D. Bentley,et al.  Mutation detection by fluorescent chemical cleavage: application to hemophilia B. , 1994, PCR methods and applications.

[11]  Hui Tian,et al.  BRCA1 physically associates with p53 and stimulates its transcriptional activity , 1998, Oncogene.

[12]  J. Klijn,et al.  Rapid detection of BRCA1 mutations by the protein truncation test , 1995, Nature Genetics.

[13]  A. Ashworth,et al.  A missense mutation in the BRCA2 gene in three siblings with ovarian cancer. , 1998, British Journal of Cancer.

[14]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Gross,et al.  A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC , 1999, Human Genetics.

[16]  D. Livingston,et al.  Genetic analysis of BRCA1 function in a defined tumor cell line. , 1999, Molecular cell.

[17]  J. Uitto,et al.  Cloning of the human type XVII collagen gene (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa. , 1997, American journal of human genetics.

[18]  P. Underhill,et al.  Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. , 1999, Human molecular genetics.

[19]  D J Prockop,et al.  Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[21]  A. Ashworth,et al.  Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.

[22]  R. Eeles,et al.  No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group. , 1997, British Journal of Cancer.

[23]  A. Ganguly,et al.  High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families , 1998, Human Genetics.

[24]  J. D. den Dunnen,et al.  Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. , 1994, Genomics.

[25]  Phang-lang Chen,et al.  Expression of BRC Repeats in Breast Cancer Cells Disrupts the BRCA2-Rad51 Complex and Leads to Radiation Hypersensitivity and Loss of G2/M Checkpoint Control* , 1999, The Journal of Biological Chemistry.

[26]  B. Weber,et al.  Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. , 2000, American journal of human genetics.

[27]  F. Collins,et al.  Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[29]  M. Stratton,et al.  Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer families , 1999, British Journal of Cancer.

[30]  F. Couch,et al.  Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. , 1998, Molecular cell.

[31]  R. Cotton.  Mutation detection by chemical cleavage. , 1999, Genetic analysis : biomolecular engineering.